Global Chagas Disease Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Chagas Disease Drug

• 1.1 Definition of Chagas Disease Drug
• 1.2 Chagas Disease Drug Segment by Type
  • 1.2.1 Global Chagas Disease Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Cz-007
  • 1.2.3 Cz-008
  • 1.2.4 D-121
  • 1.2.5 DNDI-0690
  • 1.2.6 EPLBS-1246
  • 1.2.7 EPLBS-967
  • 1.2.8 Others
• 1.3 Chagas Disease Drug Segment by Applications
  • 1.3.1 Global Chagas Disease Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Chagas Disease Drug Overall Market
  • 1.4.1 Global Chagas Disease Drug Revenue (2014-2025)
  • 1.4.2 Global Chagas Disease Drug Production (2014-2025)
  • 1.4.3 North America Chagas Disease Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Chagas Disease Drug Status and Prospect (2014-2025)
  • 1.4.5 China Chagas Disease Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Chagas Disease Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Chagas Disease Drug Status and Prospect (2014-2025)
  • 1.4.8 India Chagas Disease Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Chagas Disease Drug
• 2.3 Manufacturing Process Analysis of Chagas Disease Drug
• 2.4 Industry Chain Structure of Chagas Disease Drug

3 Development and Manufacturing Plants Analysis of Chagas Disease Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Chagas Disease Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Chagas Disease Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Chagas Disease Drug Production and Capacity Analysis
• 4.2 Chagas Disease Drug Revenue Analysis
• 4.3 Chagas Disease Drug Price Analysis
• 4.4 Market Concentration Degree

5 Chagas Disease Drug Regional Market Analysis

• 5.1 Chagas Disease Drug Production by Regions
  • 5.1.1 Global Chagas Disease Drug Production by Regions
  • 5.1.2 Global Chagas Disease Drug Revenue by Regions
• 5.2 Chagas Disease Drug Consumption by Regions
• 5.3 North America Chagas Disease Drug Market Analysis
  • 5.3.1 North America Chagas Disease Drug Production
  • 5.3.2 North America Chagas Disease Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Chagas Disease Drug Import and Export
• 5.4 Europe Chagas Disease Drug Market Analysis
  • 5.4.1 Europe Chagas Disease Drug Production
  • 5.4.2 Europe Chagas Disease Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Chagas Disease Drug Import and Export
• 5.5 China Chagas Disease Drug Market Analysis
  • 5.5.1 China Chagas Disease Drug Production
  • 5.5.2 China Chagas Disease Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Chagas Disease Drug Import and Export
• 5.6 Japan Chagas Disease Drug Market Analysis
  • 5.6.1 Japan Chagas Disease Drug Production
  • 5.6.2 Japan Chagas Disease Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Chagas Disease Drug Import and Export
• 5.7 Southeast Asia Chagas Disease Drug Market Analysis
  • 5.7.1 Southeast Asia Chagas Disease Drug Production
  • 5.7.2 Southeast Asia Chagas Disease Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Chagas Disease Drug Import and Export
• 5.8 India Chagas Disease Drug Market Analysis
  • 5.8.1 India Chagas Disease Drug Production
  • 5.8.2 India Chagas Disease Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Chagas Disease Drug Import and Export

6 Chagas Disease Drug Segment Market Analysis (by Type)

• 6.1 Global Chagas Disease Drug Production by Type
• 6.2 Global Chagas Disease Drug Revenue by Type
• 6.3 Chagas Disease Drug Price by Type

7 Chagas Disease Drug Segment Market Analysis (by Application)

• 7.1 Global Chagas Disease Drug Consumption by Application
• 7.2 Global Chagas Disease Drug Consumption Market Share by Application (2014-2019)

8 Chagas Disease Drug Major Manufacturers Analysis

• 8.1 AstraZeneca Plc
  • 8.1.1 AstraZeneca Plc Chagas Disease Drug Production Sites and Area Served
  • 8.1.2 AstraZeneca Plc Product Introduction, Application and Specification
  • 8.1.3 AstraZeneca Plc Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Bayer AG
  • 8.2.1 Bayer AG Chagas Disease Drug Production Sites and Area Served
  • 8.2.2 Bayer AG Product Introduction, Application and Specification
  • 8.2.3 Bayer AG Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Daiichi Sankyo Co Ltd
  • 8.3.1 Daiichi Sankyo Co Ltd Chagas Disease Drug Production Sites and Area Served
  • 8.3.2 Daiichi Sankyo Co Ltd Product Introduction, Application and Specification
  • 8.3.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Eisai Co Ltd
  • 8.4.1 Eisai Co Ltd Chagas Disease Drug Production Sites and Area Served
  • 8.4.2 Eisai Co Ltd Product Introduction, Application and Specification
  • 8.4.3 Eisai Co Ltd Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 GlaxoSmithKline Plc
  • 8.5.1 GlaxoSmithKline Plc Chagas Disease Drug Production Sites and Area Served
  • 8.5.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
  • 8.5.3 GlaxoSmithKline Plc Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Grupo Praxis Pharmaceutical SA
  • 8.6.1 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production Sites and Area Served
  • 8.6.2 Grupo Praxis Pharmaceutical SA Product Introduction, Application and Specification
  • 8.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Humanigen Inc
  • 8.7.1 Humanigen Inc Chagas Disease Drug Production Sites and Area Served
  • 8.7.2 Humanigen Inc Product Introduction, Application and Specification
  • 8.7.3 Humanigen Inc Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Kancera AB
  • 8.8.1 Kancera AB Chagas Disease Drug Production Sites and Area Served
  • 8.8.2 Kancera AB Product Introduction, Application and Specification
  • 8.8.3 Kancera AB Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Merck & Co Inc
  • 8.9.1 Merck & Co Inc Chagas Disease Drug Production Sites and Area Served
  • 8.9.2 Merck & Co Inc Product Introduction, Application and Specification
  • 8.9.3 Merck & Co Inc Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Novartis AG
  • 8.10.1 Novartis AG Chagas Disease Drug Production Sites and Area Served
  • 8.10.2 Novartis AG Product Introduction, Application and Specification
  • 8.10.3 Novartis AG Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Oblita Therapeutics BVBA
• 8.12 Sanofi

9 Development Trend of Analysis of Chagas Disease Drug Market

• 9.1 Global Chagas Disease Drug Market Trend Analysis
  • 9.1.1 Global Chagas Disease Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Chagas Disease Drug Regional Market Trend
  • 9.2.1 North America Chagas Disease Drug Forecast 2019-2025
  • 9.2.2 Europe Chagas Disease Drug Forecast 2019-2025
  • 9.2.3 China Chagas Disease Drug Forecast 2019-2025
  • 9.2.4 Japan Chagas Disease Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Chagas Disease Drug Forecast 2019-2025
  • 9.2.6 India Chagas Disease Drug Forecast 2019-2025
• 9.3 Chagas Disease Drug Market Trend (Product Type)
• 9.4 Chagas Disease Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Chagas Disease Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List